In vitro drug susceptibility of 2275 clinical non-tuberculous mycobacteria isolates of 49 species in The Netherlands
International audience ; In this study, 2275 clinical isolates of 49 species of non-tuberculous mycobacteria isolated in The Netherlands were subjected to standardised drug susceptibility testing using the Middlebrook 7H10 agar dilution method. Clarithromycin and rifabutin were most active, with 87% and 83% of all isolates, respectively, being susceptible. Susceptibility to ciprofloxacin (44%) and amikacin (32%) was limited and was mostly restricted to , , and phylogenetically related species. Susceptibility to isoniazid (0.5%), rifampicin (37%), ethambutol (35%) and streptomycin (33%) was rar... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2009 |
Verlag/Hrsg.: |
HAL CCSD
|
Schlagwörter: | Atypical mycobacteria / Atypical infections / Macrolides |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26791412 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hal.archives-ouvertes.fr/hal-00556372 |